For millions of individuals managing Type 2 diabetes, every visit to the doctor carries the same concern; What do I do to prevent the next heart attack or stroke? A new study presented at the American ...

An enteric coating did not hurt the effectiveness of aspirin pills for secondary prevention of atherosclerotic cardiovascular disease (ASCVD), but it didn't make it any safer either, researchers found ...

People with type 2 diabetes who took low-dose aspirin were less likely to have a heart attack or stroke, University of Pittsburgh researchers reported. File Photo by Brian Kersey/UPI Low-dose aspirin ...

Opting for enteric-coated aspirin over the uncoated pills doesn’t appear to have a major impact on the drug’s antiplatelet effects in patients with atherosclerotic CVD, but nor did it offer an edge in ...

DALLAS, Nov. 3, 2025 — People with Type 2 diabetes (T2D) and an elevated risk for cardiovascular disease (CVD) who took low-dose aspirin were less likely to experience a major cardiovascular event, ...

Low-dose aspirin is no longer universally recommended to prevent heart health emergencies, but it might help people with type 2 diabetes, a new study says. People with type 2 diabetes who took ...